Fairmount Funds Management LLC Diversified Active

Location: West Conshohocken, PA

CIK: 0001802528 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value: $237M (100.0% shares, 0.0% debt)

Holdings (21)

INSM INSMED INC 13.8%
Value $32.76M Shares 961,797 Est. Cost $20.81 Unrealized +83.7%
ZOGENIX INC 11.6%
Value $27.43M Shares 1,405,259 Est. Cost $31.22 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 7.6%
Value $17.92M Shares 565,890 Est. Cost $24.87 Unrealized +66.7%
ALLAKOS INC 7.1%
Value $16.95M Shares 147,662 Est. Cost $81.12 Unrealized
AXSM AXSOME THERAPEUTICS INC 6.0%
Value $14.24M Shares 251,598 Est. Cost $79.55 Unrealized -11.6%
TRILLIUM THERAPEUTICS INC 6.0%
Value $14.21M Shares 1,323,181 Est. Cost $4.53 Unrealized
ARGX ARGENX SE 6.0%
Value $14.17M Shares 51,450 Est. Cost $163.87 Unrealized
INSTIL BIO INC 5.8%
Value $13.79M Shares 550,000 Est. Cost $25.08 Unrealized
COGT COGENT BIOSCIENCES INC 5.8%
Value $13.69M Shares 1,558,975 Est. Cost $10.99 Unrealized -12.4%
MIRATI THERAPEUTICS INC 4.9%
Value $11.61M Shares 67,800 Est. Cost $186.77 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 4.7%
Value $11.15M Shares 432,317 Est. Cost $43.17 Unrealized +2.0%
AMARIN CORP PLC 4.2%
Value $9.987M Shares 1,608,237 Est. Cost $14.24 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 3.6%
Value $8.441M Shares 171,147 Est. Cost $60.17 Unrealized -17.1%
FOLD AMICUS THERAPEUTICS INC 3.3%
Value $7.795M Shares 788,980 Est. Cost $9.80 Unrealized +58.0%
SERES THERAPEUTICS INC 3.1%
Value $7.269M Shares 353,016 Est. Cost $23.44 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 3.0%
Value $7.131M Shares 175,000 Est. Cost $43.31 Unrealized
KROS KEROS THERAPEUTICS INC 2.8%
Value $6.729M Shares 109,333 Est. Cost $63.36 Unrealized 0.0%
VERONA PHARMA PLC 0.3%
Value $702K Shares 83,944 Est. Cost $6.24 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 0.2%
Value $581K Shares 35,092 Est. Cost $18.72 Unrealized 0.0%
THERAPEUTICS ACQUISITION COR 0.2%
Value $526K Shares 50,000 Est. Cost $10.52 Unrealized
CATABASIS PHARMACEUTICALS IN 0.1%
Value $154K Shares 53,166 Est. Cost $2.90 Unrealized